| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Aftab Dana | EVP, Research & Development | C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA | /s/ Nina Ayer, Attorney in Fact | 10 Oct 2025 | 0001959132 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXEL | Common Stock | Award | $0 | +50,673 | +7.6% | $0.000000 | 713,161 | 08 Oct 2025 | Direct | F1, F2 |
| holding | EXEL | Common Stock | 5,835 | 08 Oct 2025 | By 401(k) | F3 |
| Id | Content |
|---|---|
| F1 | Represents shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon the vesting of restricted stock units ("RSUs"). The RSUs were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs will vest as to 1/4th of the original number of shares subject to the RSU award on November 15, 2026 and thereafter as to 1/4th of the original number of shares subject to the RSU award on each November 15th until fully vested. |
| F2 | Includes 431,306 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs. |
| F3 | Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of October 7, 2025. |